Jeff Glajch
Analyst · Brian Rafn of Morgan Dempsey Capital Management. Please proceed with your questions
Thank you, Jim and good morning, everyone. I'm starting on slide eight. As Jim mentioned Q3 sales were $33.6 million, up 44% compared with $23.4 million in last year's third quarter. The sales split was 55% domestic and 45% international compared to last year's third quarter which was 62% domestic and 38% international. Gross margins were up 400 basis points to 30%, the EBITDA margin was 18% for Q3, up from 11% last year. Q3 net income and EPS was $4 million and $0.39 respectively compared with $1.4 million and $0.14 in last year's third quarter. On the slide nine, looking at our year-to-date results, year-to-date sales were $97.7 million, up 28% from $76.1 million in the first nine months of last year. Year-to-date sales are more heavily weighted for domestic opportunities this year at 64% domestic, 36% international compared with 57% domestic and 43% international last year. Gross profit has increased 19% to $29 million, though gross margin is down 230 basis points to 29.7%. The higher gross profit of course is driven by increased volume, although lower gross margin was impacted by a very strong product mix in the first half of fiscal 2014. SG&A was $13.6 million in the first nine months of the year, up only 5% when compared with the first nine months of last year as we have leveraged our overhead base quite well this year. SG&A as a percent of sales is at 13.9%, down from 17% last year. EBITDA margin increased 40 basis points to 17.6% in the first nine months of this fiscal year, primarily driven by the improvement in SG&A leverage, which I just mentioned. Net income has increased 35% to $10.6 million, up from 7.8 million last year, EPS was up to $1.4 from $0.78 last year. On the slide 10, as Jim mentioned, our cash position is quite strong at $62.5 million, up from $61.1 million at the start of the fiscal year, though down sequentially from 64.8 million at the end of last quarter. This near-term decrease is simply timing of projects, and we expect that to reverse in the fourth quarter. We expect to have a strong cash flow in the fourth quarter. As you can see, we've also increased cash flow, cash over the first three quarters of this year, despite having spent $5 million dollars in capital, most of it to expand at Batavia facility. The benefit of this expansion has already been seen as we have increased loading in our plant as this year has progressed. With our strong ongoing cash generation yesterday, the Board of Directors authorized the doubling of our dividend to $0.08 per quarter and $0.32 per year. This is our third consecutive year in which we've increased the dividend which was two $0.02 per quarter prior to 2013 has now fourfold from that to $0.08 per quarter. Additionally, the Board of Directors authorized the share repurchase program of up to $18 dollars. We believe that these two capital utilization announcements confirm the strength of our conviction of our long-term strategy, the solid nature of our balance sheet and very importantly the predictability of our ongoing cash flow. Even with the increased dividend and share repurchase program, we are very confident that we have sufficient capacity, whether it be cash or debt availability to continue to pursue our acquisition strategy. Jim will complete our presentation and comment on our outlook for the rest of fiscal year 2015.